Vanguard Capital Management’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.04M Buy
2,946,084
+40,165
+1% +$78.9K ﹤0.01% 3146
2026
Q2
$7.06M Buy
2,905,919
+5,103
+0.2% +$12.5K ﹤0.01% 2985
2026
Q1
$6.87M Buy
+2,900,816
New +$10M ﹤0.01% 2927

Other funds holding ORGO

Vanguard Capital Management's ORGO Position: Q3 2026 in Review

Vanguard Capital Management increased its Organogenesis Holdings (ORGO) stake by 1.4% in Q3 2026, buying an estimated $78.9K and bringing the position to 2,946,084 shares worth $4.04M. The position accounts for ﹤0.01% of the portfolio, ranked #3146.

Vanguard Capital Management first reported a position in ORGO in Q1 2026 and has held it in 3 quarters since. The position peaked at $7.06M in Q2 2026. 123 funds tracked by Wall St. Rank hold ORGO as of Q3 2026.

  • Vanguard Capital Management held 2,946,084 shares of Organogenesis Holdings worth $4.04M as of Q3 2026.
  • Vanguard Capital Management bought 40,165 Organogenesis Holdings shares in Q3 2026, an estimated $78.9K.
  • Organogenesis Holdings made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3146 holding.
  • Vanguard Capital Management first reported a position in Organogenesis Holdings in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's Organogenesis Holdings position peaked at $7.06M in Q2 2026.
  • 123 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.